巨子 ICON - 財經股票資訊及專家分析
快訊
資訊
    虛擬市場
    搜尋 股票/指數/編號

    快訊

    資訊

    PureTech Health plc

    PRTC
    30.750
    0.280
    0.92%
    最少15分鐘延遲,股票資訊由第三方資訊供應商提供
    ・PureTech Health plc - 延遲價格・最後更新於 16/08 9:30
    最高位
    31.280
    最低位
    29.000
    開市價
    --
    前收市價
    30.470
    成交量(千)
    0.40
    成交額(百萬)
    0.12
    買入
    --
    賣出
    --
    每手股數
    --
    市值(百萬)
    874.40
    市盈率
    --
    息率
    --
    差價
    --
    52週高低
    56.460 - 18.150
    所有資料不保證絕對正確、完整、或實時,僅作為參考使用。投資涉及風險,過往業績並不代表將來表現,作任何投資決定或交易前,閣下應諮詢獨立專業意見。所有內容均不構成投資建議。

    企業資料

    公司名稱
    PureTech Health plc
    證券代碼
    PRTC.US
    所屬板塊
    Biotechnology
    公司業務
    PureTech Health PLC is a biopharma company developing medicines to modulate the adaptive human system. It is a cross-disciplinary healthcare company developing products that could improve the lives of patients. The company is focused on developing and commercializing highly differentiated medicines for devastating diseases, including inflammatory, fibrotic and immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, neurological & neuropsychological disorders, among others. It operates in following segments: Internal, Controlled Founded Entities, Non-Controlled Founded Entities, and Parent Company & Others. The company has a robust pipeline of advanced programs that are post-human proof of concept, focused on addressing some of society's healthcare needs.
    發行量
    28790140
    公司總部
    6 Tide Street, Suite 400
    公司網址
    https://www.puretechhealth.com
    公司電郵
    ir@puretechhealth.com
    公司電話
    +1 617 482-2333
    暫無內容

    關於

    PureTech Health plc(PRTC.US)所屬的行業板塊為Biotechnology。
    PureTech Health PLC is a biopharma company developing medicines to modulate the adaptive human system. It is a cross-disciplinary healthcare company developing products that could improve the lives of patients. The company is focused on developing and commercializing highly differentiated medicines for devastating diseases, including inflammatory, fibrotic and immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, neurological & neuropsychological disorders, among others. It operates in following segments: Internal, Controlled Founded Entities, Non-Controlled Founded Entities, and Parent Company & Others. The company has a robust pipeline of advanced programs that are post-human proof of concept, focused on addressing some of society's healthcare needs.
    詳細公司背景可參考: https://www.puretechhealth.com